Jarrod Longcor, Chief Business Officer at Cellectar Biosciences, Inc. (CLRB), sold 13,000 shares at $1.18 ($15K) on 2018-03-13, disclosed to the SEC on 2018-03-14.
Scheduled sale ($15k) by Chief Business Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| CLRB | BUY | 2025-03-12 | $8K | — | Filing → |
| CLRB | BUY | 2020-12-28 | $40K | — | Filing → |
| CLRB | BUY | 2020-06-08 | $150K | — | Filing → |